• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.17% Nasdaq Up 1.27%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    11.58 Up 0.13(1.14%) Apr 20, 4:00PM EDT
    Add to Portfolio
    Prev Close:11.45
    Open:11.56
    Bid:N/A
    Ask:14.56 x 1000
    1y Target Est:23.55
    Beta:5.64
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:11.20 - 11.69
    52wk Range:10.85 - 18.48
    Volume:1,250,103
    Avg Vol (3m):1,720,240
    Market Cap:1.20B
    P/E (ttm):N/A
    EPS (ttm):-1.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 1.14%1.20B
    BAX 0.00%38.18B
    SHPGUp 0.35%47.98B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):109.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.96
    Quarterly EPS Est (Mar-15) :-0.30
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback